Can Life Expectancy and QALYs Be Improved by a Framework for Deciding Whether to Apply Clinical Guidelines to Patients With Severe Comorbid Disease?
- 10 February 2011
- journal article
- Published by SAGE Publications in Medical Decision Making
- Vol. 31 (4), 582-595
- https://doi.org/10.1177/0272989x10386117
Abstract
Background: Guidelines with short-term harms and long-term benefits are often applied to chronically ill patients who may not benefit. The payoff time framework has been proposed (i.e., do not apply a guideline if a patient’s life expectancy (LE) is shorter than when a guideline’s cumulative incremental benefits first exceed its cumulative incremental harms), but its health impact is unclear. Objective: To investigate whether the payoff time framework improves LE and/or quality-adjusted life-years (QALY) for chronically ill patients. Methods: I evaluate impact of the payoff time framework on LE and QALYs, assuming (1) high and constant background mortality rate from chronic illness (≥ 10% per year), (2) immediate guideline-related harm with probability < 1, and (3) constant guideline-related benefit that occurs over an extended time. I apply the framework to questions of whether to screen chronically ill 50-year-old women for colorectal cancer using colonoscopy, and whether to advocate intensive glucose control for chronically ill diabetics. Results: If a guideline’s payoff time is greater than a patient’s LE, then withholding that guideline will increase LE and QALYs for that patient. For a 50-year-old chronically ill woman with background mortality > 0.15 per year (corresponding to LE < 6.5 years), withholding CR screening will increase LE. For a diabetic with background mortality > 0.11 per year (corresponding to LE < 9.4 years), withholding CR screening will increase QALYs. Conclusion: The payoff time framework may indicate when withholding a guideline with short-term harms and long-term benefits may increase LE and/or QALY.This publication has 17 references indexed in Scilit:
- A Framework for Tailoring Clinical Guidelines to Comorbidity at the Point of CareArchives of Internal Medicine, 2007
- PSA Screening Among Elderly Men With Limited Life ExpectanciesJAMA, 2006
- Colorectal Cancer Screening in Young Patients With Poor Health and Severe ComorbidityArchives of Internal Medicine, 2006
- Using Clinical Guidelines Designed for Older Adults With Diabetes Mellitus and Complex Health StatusJAMA, 2006
- Development and Validation of a Prognostic Index for 4-Year Mortality in Older AdultsJAMA, 2006
- Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid DiseasesJAMA, 2005
- Potential Pitfalls of Disease-Specific Guidelines for Patients with Multiple ConditionsThe New England Journal of Medicine, 2004
- Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 DiabetesJAMA, 2002
- Cancer Screening in Elderly PatientsJAMA, 2001
- A convenient approximation of life expectancy (the “DEALE”): I. validation of the methodAmerican Journal Of Medicine, 1982